Chapter 3: The Trial Hold
The first alert appeared on the black screen behind Celeste.
Not the company logo.
Not a birthday message for Sterling Biotech's hundredth year.
A regulatory notice.
AURORA-9 STUDY AUTHORIZATION: TEMPORARY HOLD PENDING RIGHTS AND RECORDS REVIEW.
Someone near the investors' table read the words aloud.
The atrium erupted.
Reporters lifted phones. Board members pushed back chairs. An analyst I recognized from financial television began speaking rapidly into a headset while the event livestream continued broadcasting every second.
Celeste turned toward the screen.
"Take that down."
Her assistant pressed at a tablet. The notice stayed.
"Take it down now."
"It isn't coming from our presentation system," the assistant whispered.
Nathan was already reading the message on his phone. Whatever remained of his public calm narrowed into concentration.
"The authorization has not been revoked," he announced. "This is a temporary administrative hold."
"On the program you planned to relaunch Monday," I said.
He looked at me. "You contacted the agency."
"The notice says why it was issued."
"You manufactured a rights dispute to interfere with a regulated study."
"That would be a serious allegation. You should avoid making it before you read the attachment."
My father took Nathan's phone from him and scrolled.
For years, Conrad had treated documents as objects other people summarized. Tonight, there was no one he trusted to stand between the page and the truth.
"Helena Research Trust," he said.
Celeste faced him. "What?"
The name moved through me with more force than hearing my own had.
My mother had created the trust before Sterling Biotech became valuable enough for men like my father to call her caution sentimental. It funded early research, protected inventor credit, and held the foundation rights to AURORA-9.
After she died, Conrad spoke of the trust as if it were a ceremonial box stored inside the company.
It wasn't.
"This notice was requested by the Helena Research Trust," he said.
"Requested?" I corrected. "The trust gave notice that its license conditions may have been breached. The agency decided what action to take."
Celeste descended the last step from the stage.
"You're hiding behind our mother's name."
"You are wearing her crown."
Her hand rose toward the silver band, then stopped before touching it.
Nathan came closer, keeping his voice low. "The trust has no standing to control current work. Sterling acquired the platform years ago."
"Then show the board the complete agreement."
"We have the agreement."
"Including Annex C?"
Silence.
It lasted less than a second, but I saw him recognize the name.
My father saw it too.
"Nathan?"
"The archival agreements are extensive. I won't confirm an attachment from memory."
That was the safest answer available to him.
It was also not a denial.
The corporate secretary opened the cream envelope with shaking fingers. Inside were three documents: a preservation demand, a notice of disputed license compliance, and a request for an emergency board meeting.
She read the first page, then looked toward the directors.
"The trust is invoking its information rights."
"On whose instruction?" Celeste asked.
Ms. Vale glanced at me.
I could have answered. I let the document do it.
My father crossed the space between us. "What position do you hold with the trust?"
"You will have the authorization before the emergency meeting."
"There will be no emergency meeting during my company's celebration."
The chairwoman of the audit committee stood from her table.
"There will be now."
Conrad turned.
She held up her phone, the same notice reflected in her glasses.
"If the flagship study is on hold and the legal department cannot confirm the governing license, we meet immediately."
Celeste looked from the directors to the cameras. The room she had controlled ten minutes earlier no longer waited for her next line.
She stepped close enough that only I could hear her.
"You planned this."
"I prepared for it."
"What's the difference?"
"Preparation leaves a record."
Behind her, the screen refreshed.
The final line of the notice appeared in bold:
UNDERLYING LICENSE: HELENA RESEARCH TRUST.